Tazocin 4g/0.5g powder for solution for infusion vials

국가: 영국

언어: 영어

출처: MHRA (Medicines & Healthcare Products Regulatory Agency)

유효 성분:

Piperacillin sodium; Tazobactam sodium

제공처:

Pfizer Ltd

ATC 코드:

J01CR05

INN (International Name):

Piperacillin sodium; Tazobactam sodium

복용량:

4gram ; 500mg

약제 형태:

Powder for solution for infusion

관리 경로:

Intravenous

수업:

No Controlled Drug Status

처방전 유형:

Valid as a prescribable product

제품 요약:

BNF: 05010104; GTIN: 5010981002813

환자 정보 전단

Page 1 of 9
PACKAGE LEAFLET: INFORMATION FOR THE USER
Tazocin
®
2 g / 0.25 g powder for solution for infusion
Tazocin
®
4 g / 0.5 g powder for solution for infusion
Piperacillin / Tazobactam
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Tazocin is and what it is used for
2.
What you need to know before you use Tazocin
3.
How to use Tazocin
4.
Possible side effects
5.
How to store Tazocin
6.
Contents of the pack and other information
1.
WHAT TAZOCIN IS AND WHAT IT IS USED FOR
Piperacillin belongs to the group of medicines known as
“broad-spectrum penicillin antibiotics”. It
can kill many kinds of bacteria. Tazobactam can prevent some resistant
bacteria from surviving the
effects of piperacillin. This means that when piperacillin and
tazobactam are given together, more
types of bacteria are killed.
Tazocin is used in adults and adolescents to treat bacterial
infections, such as those affecting the lower
respiratory tract (lungs), urinary tract (kidneys and bladder),
abdomen, skin or blood. Tazocin may be
used to treat bacterial infections in patients with low white blood
cell counts (reduced resistance to
infections).
Tazocin is used in children aged 2-12 years to treat infections of the
abdomen such as appendicitis,
peritonitis (infection of the fluid and lining of the abdominal
organs), and gallbladder (biliary)
infections. Tazocin may be used to treat bacterial infections in
patients with low white blood cell
counts (reduced resistance to infections).
In certain serious in

제품 특성 요약

OBJECT 1
TAZOCIN 4 G / 0.5 G POWDER FOR SOLUTION FOR
INFUSION
Summary of Product Characteristics Updated 07-Sep-2017 | Pfizer
Limited
1. Name of the medicinal product
Tazocin 4 g / 0.5 g powder for solution for infusion
2. Qualitative and quantitative composition
Each vial contains piperacillin (as sodium salt) equivalent to 4 g and
tazobactam (as sodium salt)
equivalent to 0.5 g.
Each vial of Tazocin 4 g / 0.5 g contains 11.35 mmol (261 mg) of
sodium.
Excipients:
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Powder for solution for infusion.
White to off-white powder.
4. Clinical particulars
4.1 Therapeutic indications
Tazocin is indicated for the treatment of the following infections in
adults and children over 2 years of
age (see sections 4.2 and 5.1):
ADULTS AND ADOLESCENTS
- Severe pneumonia including hospital-acquired and
ventilator-associated pneumonia
- Complicated urinary tract infections (including pyelonephritis)
- Complicated intra-abdominal infections
- Complicated skin and soft tissue infections (including diabetic foot
infections)
Treatment of patients with bacteraemia that occurs in association
with, or is suspected to be associated
with, any of the infections listed above.
Tazocin may be used in the management of neutropenic patients with
fever suspected to be due to a
bacterial infection.
CHILDREN 2 TO 12 YEARS OF AGE
- Complicated intra-abdominal infections
Tazocin may be used in the management of neutropenic children with
fever suspected to be due to a
bacterial infection.
Consideration should be given to official guidance on the appropriate
use of antibacterial agents.
4.2 Posology and method of administration
POSOLOGY
The dose and frequency of Tazocin depends on the severity and
localisation of the infection and expected
pathogens.
_Adult and adolescent patients_
_Infections _
The usual dose is 4 g piperacillin / 0.5 g tazobactam given every 8
hours.
For nosocomial pneumonia and bacterial infections in neutropenic
patients, the recommended dose is 4 g
piperacillin